Related references
Note: Only part of the references are listed.RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers
Zhouting Tuo et al.
BMC CANCER (2022)
Sigflow: an automated and comprehensive pipeline for cancer genome mutational signature analysis
Shixiang Wang et al.
BIOINFORMATICS (2021)
A Genotype Signature for Predicting Pathologic Complete Response in Locally Advanced Rectal Cancer
Wei-Wei Xiao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis
Tian Fang et al.
BMC GASTROENTEROLOGY (2021)
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients
Francesco Sclafani et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Regulation of GATA1 levels in erythropoiesis
Laura Gutierrez et al.
IUBMB LIFE (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
Nomogram for Predicting the Pathological Tumor Response from Pre-treatment Clinical Characteristics in Rectal Cancer
Byung-Hee Kang et al.
ANTICANCER RESEARCH (2020)
Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation
Sofia del Carmen et al.
SCIENTIFIC REPORTS (2020)
Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Sinead Toomey et al.
CANCERS (2020)
RUNX1 regulates TGF-β induced migration and EMT in colorectal cancer
Chenghao Lu et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity
Wouter Laurentius Smit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
Alissa Greenbaum et al.
CLINICAL COLORECTAL CANCER (2019)
Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome
Federico Innocenti et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway
Junhui Yu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2019)
Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancer
Rui Xing et al.
NATURE COMMUNICATIONS (2019)
KMT2A histone methyltransferase contributes to colorectal cancer development by promoting cathepsin Z transcriptional activation
Yang Fang et al.
CANCER MEDICINE (2019)
Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer
Sophia C. Kamran et al.
CLINICAL CANCER RESEARCH (2019)
RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer
Qingyuan Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer-The Impact in Intratumoral Heterogeneity
Fabiana Bettoni et al.
FRONTIERS IN ONCOLOGY (2019)
RUNX1-dependent mechanisms in biological control and dysregulation in cancer
Deli Hong et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The genomic alterations of lung adenocarcinoma and lung squamous cell carcinoma can explain the differences of their overall survival rates
Fanlu Meng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
J. Joshua Smith et al.
JAMA ONCOLOGY (2019)
Mutant p53 in colon cancer
Mizuho Nakayama et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Genome landscapes of rectal cancer before and after preoperative chemoradiotherapy
Jie Yang et al.
THERANOSTICS (2019)
The role of TGF-beta/SMAD4 signaling in cancer
Ming Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
Maxime J. M. van der Valk et al.
LANCET (2018)
Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer
In Hee Lee et al.
MEDICAL ONCOLOGY (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
Enric Domingo et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Multi-region and single-cell sequencing reveal variable genomic heterogeneity in rectal cancer
Mingshan Liu et al.
BMC CANCER (2017)
Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review
J. E. Ryan et al.
COLORECTAL DISEASE (2016)
A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC
Michael J. Schell et al.
NATURE COMMUNICATIONS (2016)
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
F. Favero et al.
ANNALS OF ONCOLOGY (2015)
Prognostic significance of BRCA1-associated protein 1 in colorectal cancer
Jianjun Tang et al.
MEDICAL ONCOLOGY (2013)
MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
Edmund A. Mroz et al.
ORAL ONCOLOGY (2013)
Mutational and expressional analyses of STAG2 gene in solid cancers
M. S. Kim et al.
NEOPLASMA (2012)
Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer
David A. Solomon et al.
SCIENCE (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
Molecular Characterization of MSI-H Colorectal Cancer by MLH1 Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening
Jenny N. Poynter et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer
R Ryan et al.
HISTOPATHOLOGY (2005)
A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision
J García-Aguilar et al.
DISEASES OF THE COLON & RECTUM (2003)
Share Paper
